Los puntos clave no están disponibles para este artículo en este momento.
The inflammatory and immune biomarker profile varies with the development and progression of type 2 diabetes. Markers of inflammation and immunity enable differentiation between the early preclinical and clinical phases of the disease, disease complications, and progression.
Großmann et al. (Wed,) studied this question.